Do entheogen-induced mystical experiences boost the immune system? Psychedelics, peak experiences, and wellness January 1, 1999
Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action December 1, 1998
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis October 14, 1996
Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens January 1, 1986
